The GALC gene helps your body break down certain fats in myelin, the protective coating around nerves. If this gene does not work well, these fats can build up and harm the brain, spinal cord, and other nerves. Pathogenic variants in the GALC gene cause Krabbe disease, a genetic condition that can lead to irritability, feeding problems, stiffness, weakness, vision loss, and loss of developmental skills. Symptoms and the age they begin can vary widely.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the instructions for making proteins, the parts of cells that do the work. Others mainly control when certain processes happen, where they take place, and how strongly they are carried out. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this topic in more detail, you can read more in the LearnHub.
Overview
GALCGene function
What if the gene works
The GALC gene helps cells break down certain fats, especially in the brain and nerves. This supports normal myelin maintenance, the protective coating around nerves.
Risk
What if the gene does not work
More disruptive variants in the GALC gene can cause Krabbe disease, which damages the brain and nerves. Infants often develop feeding problems, stiffness, and developmental loss, while milder variants may lead to later onset weakness, vision changes, or walking problems.
Treatment
What does that mean for your treatment
For people with pathogenic variants in the GALC gene, treatment choices center on timing rather than a specific medicine. Hematopoietic stem cell transplantation (a blood stem cell transplant) can help most when done before symptoms begin or very early, so predicted early onset often leads to faster referral for transplant evaluation. Care after symptoms develop is mainly supportive, while gene therapy and enzyme based treatments are still being studied.
Conditions associated with GALC
Gene function
What if the gene works
Healthy nerve signaling depends on regular upkeep of myelin, the fatty covering around nerves. The GALC gene helps your cells recycle specific fats that are part of this upkeep, especially in the brain and other nerves. Understanding what the GALC gene does in the body helps explain how nerve tissue stays well maintained over time.
Inside small recycling centers called lysosomes, the GALC gene helps break down certain fatty materials. This lets cells reuse their parts instead of letting old material linger.
This gene helps process fats that are part of myelin, the coating that helps nerves carry signals. That steady turnover supports normal maintenance of nerve insulation in the brain, spinal cord, and peripheral nerves.
The GALC gene also helps clear psychosine, a fat byproduct made during normal myelin turnover. Removing it is part of routine cell housekeeping in cells that support nerves.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help create normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GALC gene can change how the enzyme is made, folded, or transported inside the cell, so less of it reaches the lysosome (the cell’s recycling compartment) or works properly once there. This explains how variants in the GALC gene affect enzyme activity. Milder variants may leave some activity, while more severe variants can cause very little or none, which often relates to earlier or more pronounced Krabbe disease features.
How variants are linked to conditions
When both copies of the GALC gene carry pathogenic variants, they cause Krabbe disease, a rare inherited condition that can affect movement, feeding, vision, and development. GALC gene variants and Krabbe disease are most strongly linked in the early infantile form, but some people develop symptoms later in childhood, adolescence, or adulthood. Carriers usually do not develop the condition.
A variant is not necessarily a diagnosis
Genetic variants are a common and normal feature of human biology. Most do not directly affect health and simply contribute to normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, a single well-characterized variant in a certain gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GALC, risk is mainly shaped by the gene changes a person is born with, especially when harmful changes are inherited in both copies of the gene. Family history and whether both parents carry a GALC change can strongly affect the chance for a child, and there is not enough evidence to say lifestyle changes lower this risk.
Inheritance of GALC variants
Variants in the GALC gene linked to Krabbe disease are inherited in an autosomal recessive pattern. This means a child usually inherits one GALC gene variant from each parent. When both parents are carriers, each pregnancy has a 25% chance of resulting in an affected child, a 50% chance of a child who is also a carrier, and a 25% chance of a child with no familial variant. In practical terms, how GALC gene variants are inherited often becomes relevant when there is a family history or carrier testing in relatives.
What does my GALC result mean for my family?
For families with a GALC-related condition, close relatives may also carry the changed gene. Brothers and sisters of an affected child may also have the condition or be carriers, even if they seem well. Parents are usually healthy carriers, and other relatives such as aunts, uncles, and cousins may carry the same change too.
Genetic information
Genetic testing
How you find out about variants
GALC genetic testing looks for changes in your DNA using a blood, saliva, or cheek swab sample. It can help confirm a diagnosis of Krabbe disease, show whether you carry a GALC variant, and is often interpreted alongside enzyme testing to make the result clearer.
When should I consider getting a genetic test?
Consider GALC genetic testing if a newborn screen suggests Krabbe disease, a rare condition that affects the brain and nerves, if symptoms fit, or if it runs in your family. It can help confirm the diagnosis and show whether parents or relatives are carriers.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, yet how much it reveals depends on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles some medicines, so the same treatment may work well for one person but less well for another. These differences can change how quickly a drug is broken down, how strongly it acts, or how likely side effects are. This kind of variation is common and is one of several reasons medication response is not the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can shape a person’s response to medication. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how the body processes a drug or how strong its effects are. This information can support treatment decisions that are better informed and more individualized. More information on this topic is available in the LearnHub.
Drugs influenced by the GALC gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or your health are best discussed with your doctor or pharmacist.
History
The history of the GALC gene is closely tied to the medical story of Krabbe disease, first described in 1916 by the Danish neurologist Knud Krabbe. For many years, doctors recognized the condition by its pattern in infants and families before its genetic cause was clear. Initially understood only through visible traits, later recognized as tied to a specific gene, the picture became much sharper in the late 20th century. Researchers then linked the condition to low activity of the galactocerebrosidase enzyme and went on to identify the GALC gene in the 1990s. From these first observations, research expanded steadily. This work helped confirm inherited causes, improve diagnosis, and support newborn screening efforts in some regions.